Published in Anemia on December 27, 2010
Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication. Am J Med (2013) 2.37
Pulmonary complications of sickle cell disease. Am J Respir Crit Care Med (2012) 1.35
Sustained treatment of sickle cell mice with haptoglobin increases HO-1 and H-ferritin expression and decreases iron deposition in the kidney without improvement in kidney function. Br J Haematol (2016) 0.75
Molecular mechanisms of bio-catalysis of heme extraction from hemoglobin. Redox Biol (2017) 0.75
Sickle cell anemia a molecular disease. Science (1949) 21.90
Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature (1957) 6.47
Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med (1998) 5.30
Sickle-cell disease. Lancet (2004) 4.76
Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet (1987) 4.55
Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science (2009) 3.85
Hemoglobin S gelation and sickle cell disease. Blood (1987) 2.41
Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N Engl J Med (1980) 2.14
Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood (1997) 2.12
Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr (1992) 2.02
Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor. Proc Natl Acad Sci U S A (2009) 1.91
von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Blood (2002) 1.85
Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Best Pract Res Clin Haematol (2001) 1.71
Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am J Physiol Regul Integr Comp Physiol (2000) 1.60
Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels. Am J Hematol (2003) 1.53
Alpha 4 beta 1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood (1993) 1.36
Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin. J Clin Invest (1998) 1.27
Laminin binds specifically to sulfated glycolipids. Proc Natl Acad Sci U S A (1985) 1.25
P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor. Blood (2006) 1.24
Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood (1992) 1.24
Plasma hemoglobin and hemoglobin fractions in sickle cell crisis. Am J Clin Pathol (1971) 1.23
Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin. Blood (2004) 1.20
Sickle erythrocyte adherence to vascular endothelium. Morphologic correlates and the requirement for divalent cations and collagen-binding plasma proteins. J Clin Invest (1985) 1.18
Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease. Thromb Haemost (2009) 1.15
Abnormalities of the central nervous system in very young children with sickle cell anemia. J Pediatr (1998) 1.08
CD163-expressing monocytes constitute an endotoxin-sensitive Hb clearance compartment within the vascular system. J Leukoc Biol (2007) 1.05
In vivo studies of sickle red blood cells. Microcirculation (2004) 1.02
Hemolytic anemias. Diagnosis and management. Med Clin North Am (1992) 0.99
Protective role of nitric oxide in a model of thrombotic microangiopathy in rats. J Am Soc Nephrol (2001) 0.99
The role of cytokines in sickle cell disease. Ann Hematol (2000) 0.97
Increased von Willebrand factor antigen and high molecular weight multimers in sickle cell disease associated with nocturnal hypoxemia. Thromb Res (2008) 0.96
ADAMTS13 activity in sickle cell disease. Am J Hematol (2006) 0.95
Renal failure in sickle cell anemia. Hematol Oncol Clin North Am (1996) 0.93
von Willebrand factor binds specifically to sulfated glycolipids. J Biol Chem (1986) 0.91
Unusually large von Willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cells. Am J Hematol (1993) 0.90
Lactadherin mediates sickle cell adhesion to vascular endothelial cells in flowing blood. Haematologica (2007) 0.85
Reduced nitric oxide production by L-arginine deficiency in lysinuric protein intolerance exacerbates intravascular coagulation. Metabolism (1999) 0.82
Introduction: anti-adhesion therapy in sickle cell disease. Blood (2000) 0.82
Relation between serum IgA concentration and haptoglobin type. Clin Chem (1996) 0.82
Characterization of autoantibodies against sulfatide from a V-gene phage-display library derived from patients with systemic lupus erythematosus. J Immunol Methods (2004) 0.81
Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease. Thromb Haemost (2009) 1.15
Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5. Transl Res (2006) 1.14
C1qTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen. Blood (2005) 1.10
N-terminal flanking region of A1 domain in von Willebrand factor stabilizes structure of A1A2A3 complex and modulates platelet activation under shear stress. J Biol Chem (2012) 0.97
Role of lactadherin in the clearance of phosphatidylserine-expressing red blood cells. Transfusion (2008) 0.88
Molecular link between intravascular hemolysis and vascular occlusion in sickle cell disease. Curr Vasc Pharmacol (2012) 0.87
Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. Semin Thromb Hemost (2010) 0.86
Lactadherin mediates sickle cell adhesion to vascular endothelial cells in flowing blood. Haematologica (2007) 0.85
Platelet adhesion involves a novel interaction between vimentin and von Willebrand factor under high shear stress. Blood (2014) 0.84